Cargando…

RNA N (6)‐methyladenosine modification in the lethal teamwork of cancer stem cells and the tumor immune microenvironment: Current landscape and therapeutic potential

N(6)‐methyladenosine (m(6)A), the newest and most prevalent layer of internal epigenetic modification in eukaryotic mRNA, has been demonstrated to play a critical role in cancer biology. Increasing evidence has highlighted that the interaction between cancer stem cells (CSCs) and the tumor immune mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhihui, Zhang, Chaoqi, Luo, Yuejun, Zhang, Guochao, Wu, Peng, Sun, Nan, He, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473646/ https://www.ncbi.nlm.nih.gov/pubmed/34586737 http://dx.doi.org/10.1002/ctm2.525

Ejemplares similares

Comprehensive analyses of N (6)‐methyladenosine‐related long noncoding RNA profiles with prognosis, chemotherapy response, and immune landscape in small cell lung cancer
por: Luo, Yuejun, et al.
Publicado: (2022)

Identification of a Prognostic Immune Signature for Esophageal Squamous Cell Carcinoma to Predict Survival and Inflammatory Landscapes
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Landscape of N(6)-Methyladenosine Modification Patterns in Human Ameloblastoma
por: Niu, Xing, et al.
Publicado: (2020)

Function of N6-Methyladenosine Modification in Tumors
por: Zhang, Nan, et al.
Publicado: (2021)

N6-Methyladenosine RNA Modification Landscape in the Occurrence and Recurrence of Nasopharyngeal Carcinoma
por: Wang, Yu Min, et al.
Publicado: (2022)

Corrigendum to “Function of N6-Methyladenosine Modification in Tumors”
por: Zhang, Nan, et al.
Publicado: (2023)

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
por: Guo, Liting, et al.
Publicado: (2021)

N(1)-methyladenosine modification in cancer biology: Current status and future perspectives
por: Li, Jiexin, et al.
Publicado: (2022)

Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment
por: Zhang, YanJun, et al.
Publicado: (2023)

Interaction between N(6)-methyladenosine modification and the tumor microenvironment in colorectal cancer
por: Yao, Jiali, et al.
Publicado: (2023)

The Role of N(6)-Methyladenosine Modification in Microvascular Dysfunction
por: Zhang, Ye-Ran, et al.
Publicado: (2022)

Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

m(6)A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma
por: Liu, Yong, et al.
Publicado: (2022)

The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistance
por: Zhang, Yi, et al.
Publicado: (2023)

RNA N(6)-Methyladenosine Modifications and the Immune Response
por: Wang, Ya-Nan, et al.
Publicado: (2020)

RNA N(6)-methyladenosine modification in cancers: current status and perspectives
por: Deng, Xiaolan, et al.
Publicado: (2018)

Epigenetic regulation of N6‐methyladenosine modifications in obesity
por: Sun, Mingli, et al.
Publicado: (2021)

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

Tumor Necrosis Factor Family Member Profile Predicts Prognosis and Adjuvant Chemotherapy Benefit for Patients With Small-Cell Lung Cancer
por: Zhang, Zhihui, et al.
Publicado: (2021)

Tumor‐infiltrating CD8(+) T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma
por: Zhang, Zhihui, et al.
Publicado: (2021)

Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer
por: Wu, Peng, et al.
Publicado: (2022)

The importance of N6-methyladenosine modification in tumor immunity and immunotherapy
por: Zhang, Ze, et al.
Publicado: (2022)

Microenvironment modulation by key regulators of RNA N6-methyladenosine modification in respiratory allergic diseases
por: Wang, Yuting, et al.
Publicado: (2023)

N(6)-Methyladenosine RNA Modification: A Potential Regulator of Stem Cell Proliferation and Differentiation
por: Wei, Bo, et al.
Publicado: (2022)

N6-Methyladenosine-Sculpted Regulatory Landscape of Noncoding RNA
por: Zhang, Zhongyuan, et al.
Publicado: (2021)

N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma
por: Meijing, Zhang, et al.
Publicado: (2022)

Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer
por: Liu, Qiang
Publicado: (2022)

Links Between N (6)-Methyladenosine and Tumor Microenvironments in Colorectal Cancer
por: Zhang, Yundi, et al.
Publicado: (2022)

Crosstalk between N6-methyladenosine modification and circular RNAs: current understanding and future directions
por: Wang, Xin, et al.
Publicado: (2021)

The landscape of m(6)A regulators in small cell lung cancer: molecular characteristics, immuno-oncology features, and clinical relevance
por: Zhang, Chaoqi, et al.
Publicado: (2021)

Role of N6-methyladenosine RNA modification in gastric cancer
por: Ding, Si-Qi, et al.
Publicado: (2023)

The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma
por: Sun, Nan, et al.
Publicado: (2022)

N6-methyladenosine RNA modification promotes viral genomic RNA stability and infection
por: Zhang, Tianye, et al.
Publicado: (2022)

Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment
por: Wang, Dan, et al.
Publicado: (2023)

Roles of N(6)-methyladenosine (m(6)A) modifications in gynecologic cancers: mechanisms and therapeutic targeting
por: Chen, Jiahua, et al.
Publicado: (2022)

RNA N6-Methyladenosine Modifications and Its Roles in Alzheimer’s Disease
por: Zhang, Runjiao, et al.
Publicado: (2022)

N(6)-methyladenosine modification—a key player in viral infection
por: Zhang, Xiaoyue, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lo5vqt30gs6cou8ldjcnfh4mr3